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Abstract Two distinctly different membrane proteins, which
produced inclusion bodies in Escherichia coli, have been refolded
to reconstitute properties appropriate to their native counter-
parts. The method employed utilises nickel chelating chromatog-
raphy, where the solubilised inclusion bodies bind, refold and
elute. Our aims were to release a large pool of membrane protein
for functional, mutational and crystallisation screening studies. It
is hoped that the methods described here will have a general
application for other membrane proteins which have formed
inclusion bodies.
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1. Introduction
Large quantities of proteins intended for biophysical and
structural studies are often unobtainable from native sources.
These proteins or polypeptides required as engineered variants
have to be produced by the recombinant route. In the case of
membrane proteins this strategy faces a variety of problems
(see [1] for a general review). Escherichia coli is the most
widely and successfully used vehicle for the production of
large amounts of protein for biochemical investigation. The
destination, location and state of proteins produced by ho-
mologous or heterologous expression in E. coli varies consid-
erably. Factors which in£uence the success of the expression
include the host, the nature of the promoter employed, the
growth conditions, and the origin and nature of the protein of
interest. Ideally, the protein is expressed in its native and
active state in high levels, and is then puri¢ed either conven-
tionally or with the aid of puri¢cation tags appended to the
carboxy- or amino-terminus. In other cases the protein may
form insoluble aggregates, known as inclusion bodies. Inclu-
sion bodies seem to form when highly expressed recombinant
proteins cannot be tolerated as soluble proteins in the cell
cytoplasm. Although inclusion bodies have often been consid-
ered an undesirable, dead end product of protein expression,
their formation can be an advantage as their isolation from
cell homogenates is a convenient and e¡ective ¢rst puri¢cation
step. In the worst case, the protein may not express at all or
only at very low levels. In the case of membrane proteins, they
may be localised in the membranes, otherwise inclusion bodies
form or over-expression is not achieved.
The ¢nal location of a recombinant protein is quite di⁄cult
to predict and normally has to be determined empirically.
However, a few general guidelines can be applied. Firstly,
unless a protein is extremely soluble and/or benign, high ex-
pression levels tend to lead to the formation of inclusion
bodies. Secondly, the further a gene is removed in evolution-
ary distance from the homologue of the host species, the more
likely it is that problems (i.e. no over-expression or inclusion
body formation) will arise during the heterologous expression
of its product. Membrane protein expression, unsurprisingly,
is especially prone to these problems. Obviously, the best case
is the correct folding into the host membrane enabling its
subsequent solubilisation and puri¢cation. More likely the
protein will form inclusion bodies or the expression will be
extremely low, as a result of degradation or the toxic e¡ects of
membrane protein expression in the cell [2]. Best case scenar-
ios are often achieved during homologous expression. Varia-
tions in promoters used, growth conditions employed, in host
species or in selection of a protein with a greater similarity to
the host homologue, are options available in overcoming these
expression problems.
To a large extent, our poor knowledge of membrane pro-
tein structures re£ects the di⁄cult biochemistry and their low
abundance. Indeed, the known structures are examples of
those few membrane proteins available in large quantities to-
gether with a long history of biochemical research (bacterio-
rhodopsin [3], bacterial photosynthetic reaction centre [4], cy-
tochrome bc1 [5], cytochrome c oxidase [6], LH2 [7], light
harvesting complex II (LHC2) [8], photosystem I [9], porin
[10]). The problem of low abundance has been successfully
side-stepped in the case of soluble proteins by the recombi-
nant route. In contrast, the production of large quantities of
active membrane protein by over-expression is not routine.
Therefore, the development of strategies to overcome this
barrier will signi¢cantly boost membrane protein structural
research. In this regard, membrane proteins expressed as in-
clusion bodies are potentially useful. Although the proteins in
this form are inactive and insoluble, they could be an excellent
starting point for producing membrane proteins in large
quantities, provided procedures can be developed to reconsti-
tute them in vitro. This study aims to address this problem by
the reconstitution of two di¡erent membrane proteins which
form inclusion bodies upon expression in E. coli. The refold-
ing of globular proteins from inclusion bodies is becoming
routine nowadays [11], and is frequently used as a way to
produce active protein for structural and functional studies.
However, in the case of membrane proteins far less examples
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are documented. Here we describe the use of a⁄nity chroma-
tography on Ni2-chelating Sepharose to purify and fold com-
plex proteins in one step.
1.1. The chloroplast protein import machinery
The chloroplast requires an extraordinary number of nu-
clear encoded proteins to be imported and targeted for its
biogenesis, maintenance and function. The ¢rst step in this
remarkable process is the translocation across the outer and
inner envelope membranes, and is achieved by the Toc and
Tic complexes (translocons of the inner and outer envelopes
of chloroplasts) [12]. The outer envelope component (Toc) of
this complex is a multi-subunit assembly including the core
components Toc75 (putative channel), Toc86 (precursor pro-
tein receptor) and Toc34 (GTP regulatory protein). Recombi-
nant Toc75 produced by Escherichia coli forms inclusion
bodies [13].
For further insight into the mechanism of how proteins are
targeted to and traverse a phospholipid bilayer structural in-
formation is needed. This requires the crystallisation of pro-
tein in two or three dimensions for structural analysis by
electron or X-ray crystallography, which necessitates the pro-
duction of large amounts of pure and active protein. In the
case of the chloroplast protein import machinery these re-
quirements rule out the possibility of utilising native proteins
which can only be produced in microgram amounts.
1.2. The chloroplast light harvesting complex II (LHC2)
LHC2 is the most abundant protein in thylakoids of plant
chloroplasts [14]. The 25-kDa apoprotein binds chlorophyll a
and b and carotenoids, which have been localised in the 3D
electron-crystallographic structure of the trimeric complex [8].
In plant cells the apoprotein of LHC2 is synthesised in the
cytosol and imported into chloroplasts where it acquires pig-
ments and folds. This process can be mimicked in vitro with a
recombinantly derived precursor form of LHC2 and puri¢ed
chloroplasts [15]. Another route for obtaining folded LHC2 is
in vitro reconstitution of monomeric protein from polypeptide
and pigments [16,17]. The kinetics of that process has been
analysed by measuring the energy transfer from chlorophyll b
to chlorophyll a via time resolved £uorescence spectroscopy
[18]. Trimerisation and crystallisation of recombinant mono-
mers is only possible in the presence of speci¢c lipids, and
preliminary structural maps of the recombinant complex are
consistent with the native LHC2 structure [19,20].
2. Materials and methods
Sodium N-lauroyl-sarcosinate, also known as sarkosyl, (MicroSe-
lect) was purchased from Fluka and Triton X-100 from Boehringer
Mannheim. n-Octyl-L-D-glucoside and n-dodecyl-L-D-maltoside were
purchased from Calbiochem. Chelating Sepharose Fast Flow, a pre-
packed Superdex 200 prep. grade gel ¢ltration column and standard
proteins for gel ¢ltration calibration were obtained from Pharmacia
Biotech. Other chemicals were obtained from Merck and Sigma.
2.1. Analytical methods
SDS-polyacrylamide gel electrophoresis was performed using
6U8U0.1-cm gels (Biorad Mini-Protean-Apparatus) with 12% acryl-
amide [21] and proteins were visualised by staining with Coomassie
brilliant blue dye. Native gel electrophoresis was performed without
SDS in the gels, with 10% glycerol in the samples. Electrophoresis was
carried out at 130 V at 4‡C in the dark. Chlorophyll concentration
was determined according to [22] in 80% acetone. Fluorescence meas-
urements were performed at room temperature on a Hitachi F-4500
apparatus, the excitation slit was set to 1 nm and the emission slit to 5
nm bandwidth.
2.2. Construction of Toc75 expression clones
The Toc75 expression vector (pET.24 driven by a T7 promoter
utilising the lysogen V DE3) was constructed in the laboratory of J.
Soll as described elsewhere [13].
2.3. Production of recombinant Toc75 protein (inclusion body
preparation)
A colony of recently transformed E. coli strain c41 (DE3) [2] was
inoculated into 1 l of LB growth media containing 25 Wg/ml kanamy-
cin. Cells were grown to an optical density of 0.6, whereupon IPTG
(0.6 mM) was added to induce expression. After a further 3 h the cells
were harvested by centrifugation and frozen. Cells were thawed and
resuspended in 40 ml of cold 20 mM Tris-Cl, pH 8, 1 mM EDTA
(TE) and lysed by one passage through a 40-ml pre-chilled French
pressure cell. The lysate was kept on ice and PMSF was added to a
¢nal concentration of 0.001% (w/v). Inclusion bodies were pelleted by
centrifugation (12 000Ug, 20 min, 4‡C) and washed by resuspension
in the 40 ml of TE bu¡er and re-centrifuged. After resuspension in the
same bu¡er the samples were frozen (s 20 mg/ml).
2.4. Refolding of Toc75 inclusion bodies
Typically 25 mg of Toc75 inclusion bodies were centrifuged
(12 000Ug, 10 min, 4‡C) and resuspended in 40 ml of 0.1 M Tris-
Cl, pH 8, then re-centrifuged and resuspended in 5 ml of 0.1 M Tris-
Cl, pH 8 (5 mg/ml). The isolated inclusion bodies were solubilised by
addition of 20 ml of 8 M urea and 2.7 ml of 10% sodium N-lauroyl-
sarcosinate (w/v) and after mixing the volume was brought to 50 ml
with 20 mM Tris-Cl, pH 8, 0.2 M NaCl. 10% (v/v) glycerol and 0.1%
(w/v) sodium N-lauroyl-sarcosinate (¢nal concentration 0.5 mg/ml
Toc75, 3.2 M urea, 0.6% (w/v) sodium N-lauroyl-sarcosinate and 90
mM NaCl). This mixture was slowly applied to a 3-ml Ni-chelated
Sepharose Fast Flow column equilibrated with 20 mM Tris-Cl, pH 8,
0.2 M NaCl, 10% (v/v) glycerol and 0.1% (w/v) sodium N-lauroyl-
sarcosinate at room temperature (23‡C). The column was then washed
for several hours with 100 ml of the same bu¡er except that the
sodium N-lauroyl-sarcosinate had been replaced by 0.1% (v/v) Triton
X-100. The column was again washed with 25 ml of the same Triton
bu¡er including 10 mM imidazole to remove weakly bound contam-
inants. Toc75 was eluted in one step with 0.3 M imidazole in the same
bu¡er. Protein was detected in the eluent by the Bradford assay (Bio-
rad) and by SDS-PAGE. Appropriate fractions were pooled and their
protein concentration was estimated by BCA (Pierce). Samples were
stored at 320‡C.
2.5. Size exclusion chromatography
A Superdex 200 prep. grade (60U1.6 cm i.d., 120 ml) was equili-
brated in 20 mM Tris-Cl, pH 8, 0.2 M NaCl. 10% (v/v) glycerol, 5 mM
DTT and 0.1% (v/v) Triton X-100. A sample of refolded and frozen
Toc75 (0.5 ml, 1.5 mg/ml) was thawed and applied to the equilibrated
column at 1 ml/min. Fractions were analysed by SDS-PAGE. Using
identical conditions the same column was calibrated with 2 ml (ca.
2 mg/ml) of blue dextran (2000 kDa), ferritin (440 kDa), catalase (232
kDa), aldolase (158 kDa), albumin (67 kDa), ovalbumin (43 kDa) and
RNase (13.7 kDa).
2.6. Construction of His-tagged LHCP expression clones
The Cab, AB 80 gene encoding the precursor form of pea LHC2
apoprotein (LHCP) (lhcb1*2, [24]) was modi¢ed by site-directed PCR
mutagenesis using primers that generated an XmaI restriction site at
the location corresponding to Val229. With this restriction site a short
synthetic DNA fragment was ligated extending the native cab gene by
six histidine codons. Finally a 5P DNA fragment of the Cab gene was
exchanged via the EcoRI and BstEII restriction sites with the one
coding for the mature N-terminal sequence (MRKSA....) from the
expression plasmid D7f.3 (Dilly-Hartwig, H., unpublished results).
LHCP expression and puri¢cation of inclusion bodies was performed
as described elsewhere [23].
2.7. LHC2 refolding
Inclusion bodies were dissolved in 1 ml of 8 M urea at a protein
concentration of 1 mg/ml and loaded on a 2-ml Ni a⁄nity column at
room temperature at 0.6 ml/min. The column was then washed with
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5 ml of LDS bu¡er (see below) followed by 2 ml of OG bu¡er at 4‡C.
Chlorophyll (1 mg, a/b = 1.5) and 0.3 mg of carotenoids were dis-
solved in 70 Wl ethanol and mixed with 0.7 ml of OG bu¡er, applied
to the column and incubated for 30 min (with the £ow stopped).
Afterwards the £ow was continued with 1 ml of OG bu¡er, 4 ml of
TX bu¡er and ¢nally with ELUATE bu¡er. Bu¡ers: LDS: 2% (w/v)
Li-dodecylsulfate, 0.1 M Tris, pH 9.0, 0.1 M NaCl, 20 mM imidazole;
OG: 1% (w/v) octyl-glucoside, 0.1 M Tris, pH 9.0, 12.5% (w/v) su-
crose; TX: 0.05% (v/v) Triton X-100, 0.1 mg/ml L-phosphatidyl-D,L-
glycerol dipalmitoyl (PG), 0.1 M Tris, pH 7.5; ELUATE: 0.05% (v/v)
Triton X-100, 0.1 g/l PG, 10 mM Tris, 0.3 M imidazole, pH 7.5.
3. Results
3.1. Production of recombinant Toc75 protein (inclusion body
preparation)
The yield of inclusion bodies was around 70 mg of protein
per litre of cell culture (BCA assay, Pierce). At this stage
Toc75 was already ca. 80% pure (Fig. 1, lane A).
3.2. Refolding of Toc75 inclusion bodies
Analysis of fractions by SDS-PAGE revealed that pure
Toc75 had eluted from the Ni-column (Fig. 1, lanes B and
C) indicating that the protein is now soluble in a mild deter-
gent solution. Activity measurements were performed in a
manner described elsewhere [13]. The protein was incorpo-
rated into phospholipid membranes, which subsequently
formed aqueous pores blocked speci¢cally by the precursor
small subunit of Rubisco (and not by the mature subunit)
[13]. The material exhibited the same properties except that
the apparent e⁄ciency of reconstitution was much higher than
previously described [13] (Wagner and Collinson, unpublished
results). The protein was recovered from the column in 4 ml at
0.5 mg/ml (BCA assay) from 25 mg of protein, which is an 8%
yield. Taking into account that inclusion body protein deter-
minations are usually over-estimated, the e⁄ciency is prob-
ably somewhat higher. An estimation by band intensities of
SDS-PAGE of material before and after refolding indicates
the yield is about twice as much.
3.3. Size exclusion chromatography of Toc75
Gel ¢ltration (Fig. 2A) was used as a test for the oligomeric
state of the sample. No protein was recovered at the void
volume indicating that there is no aggregation. Indeed,
Toc75 was recovered at a volume corresponding to 60 kDa
(Fig. 2B) which would suggest a monomeric form in Triton X-
100.
3.4. Tryptophan £uorescence of Toc75
To assess the folding state of Toc75, tryptophan £uores-
cence spectroscopy was employed (Fig. 3). The results ob-
tained were similar to those observed for the porin OmpA
[29]. Folded Toc75 emission peaks at 342 nm, while the
same sample unfolded in urea emits with a decrease in inten-
sity and a shift to 353 nm; unfolded inclusion bodies exhibited
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Fig. 2. Analysis of refolded Toc75 by size exclusion chromatogra-
phy. A: Fractions from the gel ¢ltration column were visualised by
SDS-PAGE. S denotes the starting material before column chroma-
tography of which 20 Wl was loaded onto the gel. Also 20 Wl of
fractions at a given elution volume were applied. The void volume
of the column corresponds to the ¢rst elution lane at 46 ml. B: The
Superdex 200 column was calibrated with molecular weight stand-
ards and the elution volume was plotted against log10 MW.
Fig. 1. Polyacrylamide gel analysis of Toc75 before and after Ni2-
column chromatography. Samples were applied to a 12% gel. Lane
A: 20 Wl (from 50 ml) of solubilised inclusion bodies prior to load-
ing onto the Ni2-column; lane B, C: 10 Wl (each from 2 ml) of
consecutive protein containing fractions from the Ni2-column.
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an intermediate peak of 346 nm. Perhaps the intermediate
result for the inclusion bodies signi¢es a resistance to unfold-
ing of inclusion bodies relative to the folded counterpart;
alternatively, it could be a result of contaminating proteins
of inclusion bodies which are stable in urea. These observa-
tions (a decrease in intensity and a shift to longer wave-
lengths) were also noted in the case of OmpA [29].
3.5. LHC2 refolding
The solubilised inclusion bodies were applied to the Ni-col-
umn and were subjected to a bu¡er change from the harsh
detergent (LDS) to a milder one (OG); upon the addition of
pigments folding proceeds. Washing with bu¡er removed
most of the pigments, but the column retained a pale green
colour, which represents the protein bound pigment. This
material was eluted with high imidazole (Fig. 4). The green
native gel is partially denaturing, therefore the trimeric as well
as monomeric form of LHC2 is observed.
The established and most accurate method for LHC2 quan-
ti¢cation is by measuring the chlorophyll content. Therefore,
the yield of refolding is conveniently expressed as the amount
of chlorophyll in the elution peak relative to chlorophyll used
in the reconstitution mixture. This gives a value of 3%, which
is calculated as 5% with respect to protein. The chlorophyll
which is not incorporated into LHC2 is not bound to the
column and is washed o¡. The non-folded protein elutes to-
gether with the folded one and can be easily separated by
further puri¢cation steps. In short, the overall yield is com-
parable with the published protocol, while the method de-
scribed here is more conveniently performed in a single step.
The quality of material is also improved, as the ratio of trimer
to monomer is higher than in samples produced by the old
method [31].
When the peak from the column is loaded on a sucrose
density gradient, a discrete band forms. The chlorophyll a
to b ratio of the band corresponds to the eluting fractions
from the column; with the value of 1.3 it has marginally
decreased in relation to the initial reconstitution conditions.
3.6. Measurement of LHC2 £uorescence transfer
The £uorescence spectrum of the complex which elutes
from the column, shows e⁄cient energy transfer from chloro-
phyll b to chlorophyll a as in native LHC2 (Fig. 5). The
broadening of the peak at low wavelength is indicative of
some incomplete transfer due to free chlorophyll or partially
misoriented chlorophylls. For comparison an emission spec-
trum of the pigment suspension as used for refolding in OG
bu¡er is shown, which yields almost no transfer.
4. Discussion
Here we report the e¡ective refolding of two quite di¡erent
membrane proteins by a related procedure: Toc75 and LHC2,
a pigment binding oligomeric assembly.
Recombinant Toc75 and LHCP from inclusion bodies bind
by virtue of their His-tags to the Ni-column. Subsequently,
exchange from chaotrope to mild detergent leads to refolding,
and in the case of LHC2 to pigment binding and trimerisation
by exposing the complex to mixed lipid-detergent micelles
[25] ; trimerisation presumably occurs as the monomers are
released from the column.
In each case the samples seem to represent the native struc-
tures and are therefore suitable for further structural and
functional analysis. The advantage of using such a refolding
approach where the proteins are immobilised on a column
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Fig. 5. Fluorescence spectra of refolded LHC2 and pigments. The
excitation wavelength is set to chlorophyll b at 469 nm. Left peak
at 655 nm: pigment mixture used for refolding in OG bu¡er, 50-
fold dilution. Right peak at 679 nm: recombinant LHC2 fraction
eluted from Ni-column.
Fig. 4. Green native gel of LHC2 eluting from Ni2-column. Lane
1: reference native LHC2 (pea); lane 2: unbound pigments washed
o¡ with OG and TX-bu¡er; lanes 3^6: elution of refolded LHC2
with ELUATE bu¡er.
Fig. 3. Fluorescence spectra of refolded and denatured Toc75. The
excitation wavelength was set at 296 nm for absorption by trypto-
phan. The full line represents the emission for refolded Toc75 (0.25
mg/ml protein, 20 mM Tris-Cl, 0.2 M NaCl, 0.05% (w/v) Triton,
0.05% (w/v) dodecyl maltoside, 10% (w/w) glycerol) and the long
dashed line is the same sample with 8 M urea added; the short
dashed line shows the emission for the equivalent quantity of inclu-
sion bodies (8 M urea). In all cases the bu¡er blank was subtracted.
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may be that aggregation is prevented. Proteins are immobi-
lised so that the hydrophobic faces exposed in partially folded
and folding proteins are then not free to associate with one
another. In this respect the column material may have a chap-
erone-like function in keeping folding proteins separated.
A few membrane proteins have been refolded from inclu-
sion bodies; a G-protein coupled receptor involved in olfac-
tion [26] was refolded using a similar approach. Inclusion
bodies were solubilised in N-lauroyl-sarcosinate and were
then exchanged into digitonin while the protein was bound
to a nickel chelated column. An odorant binding capability
was subsequently demonstrated. However, no data on the
yields of refolding were given nor was the aggregation state
of the detergent solubilised protein assessed. Refolding of re-
combinant porins from inclusion bodies has also been re-
ported. Porins from Rhodopseudomonas blastica [27] and a
type-b porin from Haemophilus in£uenzae [28] seem to be
quite amenable to refolding into their trimeric state. The for-
mer example makes use of an anion exchange column to ex-
change from chaotrope to LDAO and to C8E4, which seems
similar to the approaches applied here. Further, the reconsti-
tuted trimers have been shown to readily form crystals iden-
tical to those from the native source. In the latter case refold-
ing occurred by dialysis of the chaotrope employed to
solubilise the inclusion bodies and in the presence of 3,14-
zwittergent and the correct salts, then trimers could form. It
should be stated that porins are particularly robust proteins
which fold spontaneously even when unfolded protein is di-
luted with detergent solution or lipid suspension [29]. This
approach does not work with Toc75 or LHC2. The oxoglu-
tarate carrier from bovine heart mitochondria over-expressed
in E. coli as inclusion bodies has also been refolded and a
reconstituted activity demonstrated [30]. The method em-
ployed also utilised the detergent sarkosyl, and the activity
was reconstituted by addition of Triton and lipids, followed
by detergent removal by adsorption onto amberlite beads. It is
also possible to reconstitute bacteriorhodopsin inclusion
bodies by sequential exchanges form harsh (SDS) to milder
(Triton X-100) detergents, and ¢nally to octyl-glucoside also
by anion exchange chromatography [31]. Another interesting
refolding strategy utilises a column with a bound fragment of
GroEL (a mini-chaperone) [32]. This column was reported to
have considerable refolding activity. However, its application
as a general tool for processing large amounts of inclusion
bodies needs to be tested, as does its application towards
membrane proteins requiring detergents.
To understand the folding, pigment binding and trimerisa-
tion process in LHC2, biochemical and mutational perturba-
tions have been applied [33,34]. With the new method de-
scribed here future experiments can be performed in an
improved and accelerated manner. Likewise, structural infor-
mation of Toc75, as an example of a protein translocation
pore, will require extensive screens consuming large amounts
of protein. These experiments are underway using reconsti-
tuted, inclusion body derived material.
The approach of refolding membrane protein inclusion
bodies while immobilised on chelating Sepharose (or other
resins) has been shown to be useful for both K-helical and
L-barrelled membrane proteins. Moreover, in the case of
LHC2 in one step the polypeptide has folded, bound the re-
quired pigments and lipid, and trimerised into its functional
state. Therefore, we believe this approach will be more gen-
erally applicable.
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